Charles Ernst

TRP channels have been associated with an extraordinary breadth of physiological processes, including sensory transduction, metabolism, inflammation, vascular regulation, immunity, neuronal signaling, and cellular adaptation. This remarkable diversity raises the question of whether these observations reflect a common systems level biological function. We hypothesize that mitochondria are best understood as adaptive energy–information processing organelles, whose physiological state emerges from the continuous integration of multiple signaling pathways. Here, energy–information processing refers to the continuous integration of energetic state and signaling information to regulate adaptive cellular responses. In this framework, a biological transistor is a biological regulator that integrates diverse physical and chemical inputs into a controlled intracellular signaling output. Within this framework, TRPV1 and TRPV4 are hypothesized to function as biological transistors, integrating mechanical, thermal, chemical, and metabolic inputs into localized calcium nanodomains that help orchestrate mitochondrial energy–information processing. We suggest that localized calcium signaling constitutes a primary intracellular information currency, acting together with other ionic, metabolic, and mechanical signaling pathways to coordinate mitochondrial bioenergetics, redox regulation, cytoskeletal organization, and adaptive cellular responses. This hypothesis emerged not from a single experimental observation, but from the recognition of recurring patterns across cell biology, mitochondrial physiology, pharmacology, and systems biology. We suggest that the remarkable breadth of TRPV1 and TRPV4 function may be more readily understood if these channels occupy strategic regulatory positions within mitochondrial signaling networks rather than acting solely as isolated sensory ion channels. The presentation will explore the evolutionary, structural, physiological, pharmacological, and consciousness implications of this framework, including how both the successes and limitations of TRP-targeted pharmacology may be interpreted within a systems level model of mitochondrial energy–information processing. It will also examine the relationship of this framework to broader theories of consciousness, including proposals by Stuart Hameroff that synaptic transmission alone may be insufficient to explain consciousness and by Nick Lane that mitochondrial signaling and bioenergetics may contribute fundamentally to biological information processing.